Area of research
Oncology · Cancer Research
Research interest
Research interests include Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Immunotherapy and Biomarkers, and HER2/EGFR in Cancer Research.
Safety and efficacy of TQB2102, a novel bispecific anti-HER2 antibody–drug conjugate, in patients with advanced solid tumors: Preliminary data from the first-in-human phase 1 trial.
Tibremciclib or Placebo Plus Fulvestrant in Hormone Receptor–Positive and <i>ERBB2</i>-Negative Advanced Breast Cancer After Endocrine Therapy
The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing
The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer
Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway